Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer
Clinical trial NCT03197467 · COMPLETED
Trial details
- NCT number
- NCT03197467
- Sponsor
- AIO-Studien-gGmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-18
- Primary completion
- 2021-10-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.